2026 Q1 Portfolio Activity
In 2026 Q1, Catalio Capital Management, LP maintained a portfolio of 54 distinct positions. The most significant new addition was BRIDGEBIO PHARMA INC, now representing 6.70% of the total fund value. They heavily accumulated shares in TERNS PHARMACEUTICALS INC, increasing the position by 198.7%. Conversely, Catalio Capital Management, LP completely exited their position in BRIDGEBIO ONCOLOGY THERAPEUT.
Position History
hover any row below to update
Loading…
Total Positions
54
Quarter
2026 Q1
Top Holding
DNTH (9.8%)
Top 10 Concentration
54.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 54
Catalio Capital Management, LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 9.82% | 4.76% |
#1
5
Prev: #6
|
6.4 |
—
|
-93,264 | -14.3% |
P
S
|
560,308 | $47,021,047 |
$21.80
+296.7%
|
2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 6.70% | — |
#2
Prev: #—
|
7.7 |
—
|
432,014 | — |
NEW
|
432,014 | $32,081,360 |
$27.92
+147.6%
|
2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 6.17% | 4.49% |
#3
4
Prev: #7
|
5.5 |
—
|
9,846 | 8.3% |
P
S
|
129,111 | $29,531,559 |
$141.65
+74.4%
|
2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 5.33% | 6.18% |
#4
2
Prev: #2
|
2.6 |
—
|
-227,172 | -35.1% |
P
S
|
420,727 | $25,517,093 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 5.09% | 4.44% |
#5
3
Prev: #8
|
3.0 |
—
|
-153,137 | -12.8% |
P
S
|
1,043,670 | $24,380,131 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 4.77% | 6.28% |
#6
5
Prev: #1
|
1.9 |
—
|
-125,407 | -43.3% |
P
S
|
163,905 | $22,843,440 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 4.50% | 0.98% |
#7
25
Prev: #32
|
4.8 |
—
|
272,073 | 198.7% |
P
S
|
409,031 | $21,564,114 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 4.10% | — |
#8
Prev: #—
|
5.1 |
—
|
1,037,984 | — |
NEW
|
1,037,984 | $19,617,898 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 4.04% | 2.95% |
#9
3
Prev: #12
|
4.6 |
—
|
217,468 | 60.4% |
P
S
|
577,808 | $19,345,012 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 3.92% | 6.07% |
#10
7
Prev: #3
|
2.1 |
—
|
-61,110 | -17.0% |
P
S
|
299,318 | $18,782,205 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 3.72% | 0.66% |
#11
22
Prev: #33
|
4.5 |
—
|
688,247 | 423.4% |
P
S
|
850,797 | $17,824,197 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INCY
INCYTE CORP
|
Healthcare | 3.58% | — |
#12
Prev: #—
|
4.9 |
—
|
182,101 | — |
NEW
|
182,101 | $17,139,346 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.97% | 2.90% |
#13
Prev: #13
|
1.7 |
—
|
-42,880 | -16.6% |
P
S
|
215,501 | $14,203,671 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTRA
NATERA INC
|
Healthcare | 2.96% | 2.52% |
#14
2
Prev: #16
|
3.2 |
—
|
8,634 | 13.9% |
P
S
|
70,907 | $14,180,691 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 2.73% | — |
#15
Prev: #—
|
4.6 |
—
|
891,933 | — |
NEW
|
891,933 | $13,048,980 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 2.57% | 3.11% |
#16
5
Prev: #11
|
1.5 |
—
|
2,478 | 1.0% |
P
S
|
255,379 | $12,309,268 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 2.48% | 2.13% |
#17
4
Prev: #21
|
3.5 |
—
|
107,192 | 32.3% |
P
S
|
439,041 | $11,893,621 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 2.42% | 2.82% |
#18
4
Prev: #14
|
1.0 |
—
|
-42,441 | -22.7% |
P
S
|
144,607 | $11,580,129 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
VERADERMICS INC
|
|
Unknown | 2.29% | — |
#19
Prev: #—
|
4.4 |
—
|
173,582 | — |
NEW
|
173,582 | $10,961,703 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
ADPT
ADAPTIVE BIOTEC...
|
Healthcare | 2.10% | 2.36% |
#20
3
Prev: #17
|
1.3 |
—
|
-98,411 | -12.0% |
P
S
|
722,784 | $10,032,242 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HTFL
HEARTFLOW INC
|
Healthcare | 2.05% | 0.59% |
#21
13
Prev: #34
|
3.8 |
—
|
289,731 | 254.5% |
P
S
|
403,588 | $9,819,296 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 1.79% | — |
#22
Prev: #—
|
4.2 |
—
|
426,551 | — |
NEW
|
426,551 | $8,586,472 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.68% | 1.22% |
#23
7
Prev: #30
|
3.7 |
—
|
202,771 | 70.3% |
P
S
|
491,116 | $8,029,747 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.64% | 1.55% |
#24
2
Prev: #26
|
2.7 |
—
|
12,551 | 11.4% |
P
S
|
122,978 | $7,863,213 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 1.48% | 1.45% |
#25
3
Prev: #28
|
1.6 |
—
|
no change | no change |
P
S
|
294,360 | $7,073,471 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.10% | 2.35% |
#26
8
Prev: #18
|
0.4 |
—
|
-51,321 | -52.1% |
P
S
|
47,193 | $5,254,941 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.07% | 1.80% |
#27
2
Prev: #25
|
0.4 |
—
|
-236,761 | -45.6% |
P
S
|
282,954 | $5,129,956 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 1.06% | 0.34% |
#28
10
Prev: #38
|
2.9 |
—
|
379,996 | 30.2% |
P
S
|
1,639,816 | $5,050,633 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 1.04% | 0.19% |
#29
12
Prev: #41
|
3.4 |
—
|
754,725 | 527.8% |
P
S
|
897,709 | $5,000,239 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 0.67% | 2.26% |
#30
11
Prev: #19
|
0.3 |
—
|
-195,446 | -75.9% |
P
S
|
62,019 | $3,205,762 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 0.63% | 1.36% |
#31
2
Prev: #29
|
0.3 |
—
|
-866,230 | -59.9% |
P
S
|
580,024 | $3,021,925 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 0.58% | 2.05% |
#32
10
Prev: #22
|
0.2 |
—
|
-451,229 | -64.6% |
P
S
|
247,767 | $2,752,691 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 0.56% | — |
#33
Prev: #—
|
3.7 |
—
|
83,554 | — |
NEW
|
83,554 | $2,674,564 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 0.54% | — |
#34
Prev: #—
|
3.7 |
—
|
67,285 | — |
NEW
|
67,285 | $2,577,016 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.53% | — |
#35
Prev: #—
|
3.7 |
—
|
84,352 | — |
NEW
|
84,352 | $2,543,213 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GUTS
FRACTYL HEALTH ...
|
Healthcare | 0.53% | 2.14% |
#36
16
Prev: #20
|
1.2 |
—
|
no change | no change |
P
S
|
5,491,866 | $2,514,176 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HYPR
HYPERFINE INC
|
Healthcare | 0.30% | 0.23% |
#37
2
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
1,320,041 | $1,425,644 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MGX
METAGENOMI THER...
|
Healthcare | 0.15% | 0.15% |
#38
4
Prev: #42
|
1.1 |
—
|
no change | no change |
P
S
|
528,993 | $708,851 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ATAI
ATAIBECKLEY INC
|
Healthcare | 0.15% | 0.14% |
#39
4
Prev: #43
|
1.1 |
—
|
no change | no change |
P
S
|
196,858 | $696,877 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNSE
SENSEI BIOTHERA...
|
Healthcare | 0.10% | 0.03% |
#40
5
Prev: #45
|
1.0 |
—
|
no change | no change |
P
S
|
14,718 | $463,911 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OM
OUTSET MED INC
|
Healthcare | 0.09% | 0.08% |
#41
3
Prev: #44
|
1.0 |
—
|
no change | no change |
P
S
|
118,279 | $454,191 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.00% | 0.19% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-10,452 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BLLN
BILLIONTOONE IN...
|
Healthcare | 0.00% | 0.37% |
Sold All 😨
(Was: #37) |
0.0 |
—
|
-25,505 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 0.40% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-201,301 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GRAL
GRAIL INC
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-30,313 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.00% | 1.18% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-267,058 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 0.00% | 1.53% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-714,501 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ACLX
ARCELLX INC
|
Healthcare | 0.00% | 1.80% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-156,109 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 0.00% | 1.82% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-564,461 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.00% | 2.72% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-27,209 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 54 holdings